Company's Expanding Nationwide Network to Attract Health-Conscious Consumers to Preserve Their Own Stem Cells for Future Use Mar 21 2007

NEW YORK--(BUSINESS WIRE)—March 21, 2007 NeoStem, Inc. (OTCBB:NEOI - News), the first company to specialize in the collection, processing and storage of stem cells from healthy adult donors for personal use in times of critical medical need, invites investors to review a new Investor Fact Sheet that outlines the Company's unique technologies and strategy to capitalize on the growing market for stem cell-related services and potential medical treatments.

Stem cell therapy sales in the United States are projected to reach more than $700 million by 2010 and $8.5 billion by 2016, based on therapies being investigated.

"This Investor Fact Sheet will help explain how our proprietary technologies are designed to empower health-conscious consumers to protect their future health by taking part in the emerging practice of 'bio-insurance'," said Robin Smith, M.D., Chief Executive Officer of NeoStem.

Because of their ability to repair tissue and reverse the effects of disease and injuries, many believe stem cells are one of the most promising platforms in medical technology, with hundreds of clinical programs currently underway around the world as scientists work to develop new cures and treatments.

Much of the research to develop therapies using adult stem cells is focused on the development of "autologous" treatments - those adult stem cells that are harvested from a person's body for their own medical use. Autologous cells are thought to provide important health advantages for patients in terms of both the effectiveness and the safety of potential stem cell related treatments.

"NeoStem's processing and storage techniques and business model are designed to help consumers who want to play an active role in protecting their health by participating in advanced stem cell medical technology," said Dr. Smith. "By providing a safe and dependable method for people to store their own stem cells while they are healthy, our services and technology enable people who have family histories of heart disease, cancer and other serious health conditions to provide their future physicians the strongest possible tools for fighting these diseases."

To view and download the NeoStem Investor Fact Sheet, visit http://www.trilogy-capital.com/tcp/neostem/factsheet.html.